炎症性肠病
酚类
溃疡性结肠炎
医学
药理学
保健品
化学
重症监护医学
疾病
结肠炎
免疫学
内科学
生物化学
病理
作者
Haitao Xiao,Bo Wen,Xiangchun Shen,Zhaoxiang Bian
标识
DOI:10.2174/0929867324666171009100900
摘要
Inflammatory bowel disease (IBD) is an uncontrolled chronic inflammatory intestinal disorder, which requires medications for long-term therapy. Facing the challenges of severe side effects and drug resistance of conventional medications, to develop the strategies meet the stringent safety and effectiveness in the long-term treatment are urgent in the clinics. In this regard, a growing body of evidence confirms plant-sourced phenols, such as flavonoids, catechins, stilbenes, coumarins, quinones, lignans, phenylethanoids, cannabinoid phenols, tannins, phenolic acids and hydroxyphenols, exert potent protective benefits with fewer undesirable effects in conditions of acute or chronic intestinal inflammation through improvement of colonic oxidative and pro-inflammatory status, preservation of the epithelial barrier function and modulation of gut microbiota. In this review, the great potential of plant-sourced phenols and their action mechanisms for the treatment or prevention of IBD in recent research are summarized, which may help further development of new preventive/adjuvant regimens for IBD.
科研通智能强力驱动
Strongly Powered by AbleSci AI